Clinical Trials Logo
  1. Home
  2. Sleeping Sickness
  3. NCT03087955

Prospective Study on Efficacy and Safety of Acoziborole (SCYX-7158) in Patients Infected by Human African Trypanosomiasis Due to T.b. Gambiense — OXA002  

Trypanosomiasis, African Clinical Trial

Official title:
Efficacy and Safety Study of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis (HAT) Due to Trypanosoma Brucei Gambiense: a Multicentre, Open-label, Prospective Study

Clinical Trial Summary

The goal of this study is to assess efficacy and safety of Acoziborole (SCYX-7158) given as a single dose oral treatment for adult patients (above or equal 15) in the fasting state with T.b. Gambiense HAT

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03087955
Study type Interventional
Source Drugs for Neglected Diseases
Contact
Status Completed
Phase Phase 2/Phase 3
Start date October 11, 2016
Completion date August 28, 2020
View Details
See also
  Status Clinical Trial Phase
Terminated NCT01483170 - Multiple Dose Study to Evaluate Security, Tolerance and Pharmacokinetic of Fexinidazole (Drug Candidate for Human African Trypanosomiasis) Administered With a Loading Dose and With Food Phase 1
Terminated NCT00489658 - Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda Phase 2/Phase 3
Completed NCT03025789 - Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage Phase 3
Completed NCT02571062 - Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation Phase 1
Terminated NCT00330148 - Randomized Clinical Trial of Three Drug Combinations for Late-Stage Gambiense Human African Trypanosomiasis Phase 3
Recruiting NCT05433350 - Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric Patients Phase 2/Phase 3
Withdrawn NCT05645822 - Screen and Treat Implementation for HAT Control
Completed NCT05947604 - DDI Study of Single Oral Dose of Acoziborole With Sequential Co-administration of Midazolam and Dextromethorphan Phase 1
Completed NCT01533961 - Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158 Phase 1
Completed NCT05256017 - Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects Phase 2/Phase 3
Completed NCT00802594 - A Trial of DB289 for the Treatment of Stage I African Trypanosomiasis Phase 2
Completed NCT00146627 - Efficacy - Safety of Eflornithine-Nifurtimox Combination Versus Eflornithine to Treat Human African Trypanosomiasis Phase 3